Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge

Introduction: Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC) patients predicts response to EGFR tyrosine kinase inhibitors (TKIs). The Idylla™ system (Biocartis, Mechelen, Belgium) is a fully integrated, ca...

Full description

Bibliographic Details
Main Authors: M. Rabie Al-Turkmani, Michael A. Suriawinata, Sophie J. Deharvengt, Donald C. Green, Candice C. Black, Keisuke Shirai, Konstantin H. Dragnev, Gregory J. Tsongalis
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Practical Laboratory Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551719300976